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Abstract
Volepox virus (VPXV) was first isolated in 1985 from a hind foot scab of an otherwise healthy California vole (Microtus
californicus). Subsequent surveys in San Mateo County, CA, revealed serological evidence suggesting that VPXV is endemic
to this area, and a second viral isolate from a Pinyon mouse (Peromyscus truei) was collected in 1988. Since then, few studies
have been conducted regarding the ecology, pathology, and pathogenicity of VPXV, and its prevalence and role as a
potential zoonotic agent remain unknown. To increase our understanding of VPXV disease progression, we challenged 24
California mice (Peromyscus californicus) intranasally with 1.66103 PFU of purified VPXV. By day five post infection (pi) we
observed decreased activity level, conjunctivitis, ruffled hair, skin lesions, facial edema, and crusty noses. A mortality rate of
54% was noted by day eight pi. In addition, internal organ necrosis and hemorrhages were observed during necropsy of
deceased or euthanized animals. Viral loads in tissues (brain, gonad, kidney, liver, lung, spleen, submandibular lymph node,
and adrenal gland), bodily secretions (saliva, and tears), and excretions (urine, and/or feces) were evaluated and compared
using real time-PCR and tissue culture. Viral loads measured as high as 26109 PFU/mL in some organs. Our results suggest
that VPXV can cause extreme morbidity and mortality within rodent populations sympatric with the known VPXV reservoirs.
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Introduction
The genus Orthopoxvirus (OPXV) is the most important member
of the family Poxviridae in terms of public health and includes
viruses associated with severe febrile, rash illness in humans: Variola
virus, Monkeypox virus, Vaccinia virus, and Cowpox virus [1,2,3,4,5]. The
last few decades have seen the description of three OPXVs from
North America named after the mammal species in which they
were originally isolated: Raccoonpox virus, Skunkpox virus, and Volepox
virus [6,7,8,9,10,11]. Subsequent work has determined that the
North American OPXV (NA OPXV) species are a monophyletic
group which is the most genetically divergent within the OPXV
genus [8].
Volepox virus (VPXV) was first isolated in June of 1985 from a
hind foot scab of a healthy California vole (Microtus californicus) in
San Mateo County, CA [10]. Serological evidence for the
endemicity of VPXV in the San Francisco Bay region was
obtained through testing (hemagglutinin inhibition antibody titers)
vole serum sampled between 1983 and 1986 from separate
populations in Marin, Santa Clara, and San Mateo counties [10].
A second identical isolate was obtained from a Pinyon mouse
(Peromyscus truei) scab in 1988 on the Jasper Ridge Biological
Preserve suggesting that the virus is endemic to this region [9].
Few studies have been conducted regarding the ecology, pathology
and pathogenicity of VPXV; and its prevalence and role as a
potential zoonotic agent remains unknown. Our study investigates
the pathogenicity of VPXV within the California mouse (P.
californicus), a rodent species that often occurs sympatrically with
the presumed rodent reservoirs of VPXV.
Results
Morbidity and Mortality
By day five, several clinical signs (e.g., conjunctivitis, decreased
activity level, ruffled hair, crusty noses, and facial edema) were
observed in most of the animals along with the onset of ‘‘pox-like’’
skin lesions. Several 1–3 mm diameter epidermal hyperemias on
tails were observed; maculae and papulae were present on eyelids,
paws, ears, lips, and oral commissures. On day six, three mice had
succumbed to disease, and three more were euthanized based on
the clinical scale criteria outlined in the methodology section. On
day seven, two additional mice had expired and three more were
euthanized. Skin maculae and papulae progressed to erosions, and
petechiae were observed on internal organs during necropsy of the
deceased and euthanized animals (Fig. 1). On day eight, two more
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animals expired which generated a final mortality rate of 54%
(13/24). The eleven (7/11 males and 4/13 females) VPXV-
challenged, surviving mice had no observable signs of disease by
day 12. Sex was not significantly related to survivorship (p = 0.07).
The seven negative control animals gained weight during the study
and statistical comparisons of mean weight loss between infected
mice and negative controls were highly significant (p = 0.006).
Changes in body temperatures were not as marked as the observed
weight loss, but still significant (p = 0.03). The most substantial
weight loss was observed on days five through seven which
coincided with a decrease in body temperatures. On day twenty
one, one survivor (Peromyscus californicus (PC) 015) was euthanized
to determine if the animal had cleared infection. The rest of the
California mice (10 animals) recovered uneventfully from VPXV
infection and were included in an oral rabies recombinant vaccine
study; they were euthanized at days 35 (n = 2), 42 (n = 3), 49 (n = 3)
or 56 (n = 2) post VPXV infection.
Viral DNA and Infectious Virus Observations
Multiple tissues, secretions, and excretions collected on days six,
seven, and eight generated CT values (the cycle when fluorescence
crosses the threshold) between 15 to 40 for the NA OPXV real
time-polymerase chain reaction assay (RT-PCR), indicating the
presence of DNA specific for VPXV. The animal that was
euthanized on day 21 had VPXV DNA (CT 40) only in brain
tissue, and no viable virus was recovered. Oral, ocular, and anal
swabs of the 11 survivors were RT-PCR negative by day 21.
Samples collected throughout the study which had a CT value of
37 or below, equating to a minimum of 45 genomes of VPXV
DNA (based on the standard curve), demonstrated detectable CPE
in a single passage on BSC-40 cells. Viable virus could not be
obtained after 48 hrs from specimens with a CT of $38. The
highest observed viral titers from oral swabs were similar on days
6, 7, and 8 (16105, 36104, and 76104 PFU/mL respectively) as
were viral titers in the spleen and liver samples on days 6 and 7
(1.26108, 46108, 16108, and 26109 PFU/mL respectively). The
viral titer in the spleen and liver samples on day 8 had a decrease
of 2–3 logs compared with day 6 and 7. On day 6, the lung viral
titer measured up to 1.96109, but decreased two logs on days 7
and 8 (Fig. 2).
Humoral Immune Response
Sixteen out of twenty-four (16/24) infected California mice sera
were positive by enzyme-linked immunosorbent assay (ELISA),
and 20/24 mice sera were positive by western blots (WB). Four
animals (PC 010, 017, 024, and 027) did not have evidence of
antibody production by either ELISA or WB. The remaining
animals showed evidence of immune response in at least one assay
(Table 1). The molecular weight protein bands observed in WB
from animals which succumbed during the early phase of infection
(6 to 8 days) were 18, 21, 36, 39, and 62 kilo-Daltons (kDa). In
animals euthanized on or after day 21 (21 to 56 days), bands
weighting 11, 14, 18, 21, 25, 32, 36, 62, and 75 kDa were
observed. The 36 kDa band was immunodominant (present in
.50%) and appeared in 7/13 mice that succumbed to the
infection. The 14 kDa band was present in 9/9 survivors that
manifest humoral immune response; two of eleven survivors were
negative in both the ELISA and WB assays. The 36 and 62 kDa
bands were also prominent in survivors; these bands were present
in 6/9 and 8/9 which manifest an immune response, respectively.
Furthermore, bands 11, 14, 25, 32, and 75 kDa were observed
only in mice that survived on or past day 21 after VPXV infection
(Table 2).
Hematology
Animals that died between days six and eight had monocytosis
with values measuring between: 0.89–1.3/L (normal range of 0–
0.336109/L). These animals were also neutrophilic with values
measuring between: 4.3–6.04/L (normal range of 0.07–2.76109/
L). PC 015 showed an increase in the mean corpuscular volume
(MCV) on day 21(75 fL when the normal range is 45–55 fL).
Additionally, four mice that survived infection were sampled on
day 28 and corroborated an increase of the MCV of 72–74 fL.
Animals sampled from day six to 21 showed thrombocytopenia
with values measuring between: 115–181/L (normal range of 200–
450 6109/L).
Pathological Findings
California mice exhibited histologic changes attributable to
active virus infection (day 6 to 8) in the liver, gastrointestinal tract,
adrenal gland, spleen, and lungs. The liver demonstrated single
cell necrosis and abundant intracytoplasmic basophilic inclusions
(Fig. 3). Adrenal gland lesions were composed of clusters of
necrotic adrenal cortical cells with minimal admixed acute
inflammation. Gastrointestinal tract lesions were observed grossly
in the stomach and small intestine (Fig. 1). The squamous
epithelial portion of the stomach was multifocally hyperplastic with
prominent, intracytoplasmic eosinophilic inclusion bodies (Fig. 4).
One animal had a large focus of intraepithelial hemorrhage. The
small intestine had extensive necrosis of gut associated lymphoid
tissue (GALT) with hemorrhage and minimal epithelial necrosis.
Enterocytes adjacent to the GALT had rare intracytoplasmic
eosinophilic inclusion bodies. The splenic white pulp had extensive
necrosis. Lung lesions consisted of patchy alveolar and interstitial
Figure 1. Characteristic lesions observed on P.californicus infected with Volepox virus. Epidermal ulcers with crusting on paw (A), vulvae
and perineum (B), tongue and nares (C). Serosal petechiae and focal gastrointestinal tract necrosis (D).
doi:10.1371/journal.pone.0043881.g001
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edema with minimal mononuclear interstitial inflammation.
Eosinophilic intracytoplasmic inclusion bodies were frequently
observed in cells with the morphology of monocytes and/or type II
pneumocytes. Skin lesions consisted of multiple ulcers covered by
fibrin admixed with inflammation and necrotic cellular debris.
The subjacent dermis was composed of organized granulation
tissue and re-epithelialization was noted in some lesions from day
21.
Electron microscopic examination of the stomach, intestine,
spleen and lung revealed intracytoplasmic A-type inclusions
(ATIs). Three types of ATIs were observed; inclusions containing
virions throughout (Fig. 5A), inclusions without virions (Fig. 5B),
and inclusions with virions at the periphery (Fig. 5C). The ATIs
examined had varying morphologies that included both non-
condensed and mature virions inside and/or around the periphery
of the inclusions (Fig. 5D, E). B-type inclusions (BTIs or viral
factories) were also observed (Fig. 5F).
Mock Infected Animals
None of the negative control animals showed signs of disease
during the study. Furthermore, all samples from these control
animals were negative for volepox DNA by RT-PCR and were
negative for volepox virus anti-IgG by ELISA (Table 1). The
hematology values consistently remained in normal range.
Discussion
California mice (Peromyscus californicus) intranasally challenged
with 1.66103 PFU of VPXV in 10 ml PBS (5 ml/nostril),
developed widespread lesions after a five day incubation period.
The disease progression was acute, with a mortality rate of 54%;
survivors began to recover by day eight and no viable virus was
detectable by day 21. These data contrast with the monkeypox
virus (MPXV) prairie dog model of Orthopoxvirus infection, where
disease presentation is delayed (day 9–12) and generally persists for
a longer period of time (24–28 days) before resolution. The
mortality rate observed in prairie dogs infected with a similar
dosage of West African MPXV is 0–25% [12,13]. Although we did
not identify a febrile period in this study, it is possible that the
duration of pyrexia was very short and our sampling missed it;
unpublished data show that California mice infected with a lower
dose of VPXV (1.26102 PFU) did present a febrile period by day
14 pi. The weight loss and skin lesion onset may be related to
anorexia due to general malaise or pain associated with oral
ulceration.
The sensitivity of the NA OPXV RT-PCR is superior to viral
isolation by cell culture in the detection of infection. This
observation has been described previously using the E9L RT-
PCR assay for detection of MPXV in prairie dog studies
[12,13,14,15]. All samples with CT values of 37 (minimum of
45 genomes of VPXV) or earlier had detectable cytopathic effect
(CPE) in a single passage on BSC-40 cells, while samples with CT
values $38 did not show evidence of viable VPXV. All samples
from negative control animals were confirmed negative by both
RT-PCR and cell culture.
The 14 kDa band was the immunodominant band observed in
all survivors which manifest an immune response. This band size is
consistent with the previously described envelope protein encoded
by the A27 gene ortholog of vaccinia virus Copenhagen (VV-Cop).
This gene has an important role in allowing mature virus to bind
to cell surface glycosaminoglycans [16] and stimulates a cellular
immune response [17]. Previous experiments found that mice
immunized against the 14 kDa protein, and later challenged with
40 times the 50% lethal dose (LD50) of wild type VACV, did not
show signs of disease and had 100% survivorship [17]. Our
36 kDa band may be the previously described 37 kDa envelope
protein. This would be consistent with another study in which that
protein was immunodominant in animals that succumbed to
orthopoxvirus infection or had to be euthanized because of the
severity of the disease [18]. The 62 kDa band is likely a major core
protein encoded by the A10 gene (VV-Cop ortholog) derived from
the P4a precursor. It is the most abundant core protein found in
Figure 2. Viable virus content per specimen. Volepox virus loads (PFU/mL) per specimen taken during the necropsy of deceased and
euthanized mice on days 6, 7 and 8 pi. *Swabs from the survivors were taken on day 7 pi.
doi:10.1371/journal.pone.0043881.g002
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the virion and plays an important role in its assembly. It is also
important in stimulating memory B-cells and the humoral immune
response [17,19]. The inflammatory monocytosis and neutrophilia
in the early phase of infection was not an unexpected result given
the severity of disease observed. Although mild thrombocytopenia
was observed from day six through 21, it is unlikely to be the sole
cause of the hemorrhage. Further analysis of platelet function and
collection of clotting data throughout the duration of clinical
disease would be required to accurately define the pathogenesis of
the hemorrhage.
Histological changes attributable to active virus infection were
seen in the internal organs of those animals that succumbed to
disease. B- type basophilic intracytoplasmic inclusion bodies, also
known as ‘‘viral factories’’, are a typical histopathological feature
of poxvirus infections, but the intracytoplasmic ATIs bodies
observed ultrastructurally are not made by all members of the
genus [5]. The North American orthopoxviruses, cowpox, and
ectromelia have previously been shown to form ATIs [5,9]. Our
findings confirm that VPXV makes ATIs within infected cells.
However, VPXV makes all three types of ATIs, which has not
been reported within the genus Orthopoxvirus, but this could be a
difference between observations made from in vitro versus in vivo
systems. A-Type inclusions showed morphological variations other
than the three classic types of inclusions described. In addition
non-condensed and mature particles were seen inside and around
the periphery of the inclusions (Fig. 5D, E). Additional studies,
involving more tissue and serial thin-sections would likely provide
further insight into the overall structure and composition of ATIs.
We were not able to detect an immune response in four mice.
Although two of these mice (PC 024 and PC 027) presented with
external and internal hemorrhagic lesions with 16108 and 66107
PFU/mL in spleen, respectively. Both mice (PC 024 and PC 027)
Table 1. Correlation between volepox virus infection and immune response.
Animal ID Necropsy * Cause of death Inoculum Lesions or signs of disease ELISA ** Western Blot ***
PC 007 Day 6 D VPXV 1.6 e3 paw, tongue, vulvae, liver POS 18
PC 011 Day 6 D VPXV 1.6 e3 conjuntivitis, vulvae, tongue NEG 36,18
PC 012 Day 6 E VPXV 1.6 e3 intestine, ovaries POS 36,18
PC 014 Day 6 D VPXV 1.6 e3 tail, tongue POS 62,36,21
PC 020 Day 6 E VPXV 1.6 e3 tongue, lip, nose NEG 62,36,21
PC 030 Day 6 E VPXV 1.6 e3 tail, tongue POS 18
PC 008 Day 7 E VPXV 1.6 e3 liver NEG 36
PC 018 Day 7 E VPXV 1.6 e3 tongue, intestine NEG 62
PC 024 Day 7 D VPXV 1.6 e3 paw, eyelid, intestine, liver NEG NEG
PC 027 Day 7 D VPXV 1.6 e3 ear, tongue, intestine, kidney NEG NEG
PC 034 Day 7 E VPXV 1.6 e3 submandibular lymph node POS 62,36,21
PC 022 Day 8 D VPXV 1.6 e3 lip, adrenal gland POS 39,36,18
PC 037 Day 8 D VPXV 1.6 e3 none POS 62,21,18
PC 015 Day 21 S VPXV 1.6 e3 skin POS 62,36,25,21,14,11
PC 009 Day 35 S VPXV 1.6 e3 skin POS 62,36,14
PC 013 Day 35 S VPXV 1.6 e3 tail POS 62,36,14
PC 010 Day 42 S VPXV 1.6 e3 skin NEG NEG
PC 016 Day 42 S VPXV 1.6 e3 eyelid POS 62,32,14
PC 021 Day 42 S VPXV 1.6 e3 skin POS 62,25,21,18,14,11
PC 017 Day 49 S VPXV 1.6 e3 tail NEG NEG
PC 023 Day 49 S VPXV 1.6 e3 tail POS 75,62,36,32,25,21,18,14
PC 029 Day 49 S VPXV 1.6 e3 tail POS 62,36,14,11
PC 026 Day 56 S VPXV 1.6 e3 crusty nose POS 25,21,18,14
PC 032 Day 56 S VPXV 1.6 e3 none POS 62,36,14
PC 038 Day 7 S PBS none NEG NEG
PC 039 Day 14 S PBS none NEG NEG
PC 040 Day 21 S PBS none NEG NEG
PC 041 Day 28 S PBS none NEG NEG
PC 061 Day 35 S PBS none NEG NEG
PC 074 Day 42 S PBS none NEG NEG
PC 081 Day 49 S PBS none NEG NEG
*Days post infection.
**POS, positive.NEG, negative.
***Protein band observed, size in kDa. NEG, no band observed.
D, die due to infection. E, met the euthanasia criteria. S, study scheduled euthanasia.
doi:10.1371/journal.pone.0043881.t001
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succumbed to disease by day seven, which may be too early for
IgG detection, or may be at levels below the detection limit of our
assay. The other two mice (PC 010 and PC 017) which survived
the infection, and were euthanized on days 42 or 49 without the
production of antibodies developed single skin or tail lesions on
day 7. However the CT values (38 and 40 respectively), were
above the cutoff at which samples are considered positive for virus
particles. Previous data indicate that lesions caused by Orthopoxvirus
infection have very high amounts of Orthopoxvirus DNA which
would not be consistent with the values observed from these lesion
samples. Thus it is probable that these two animals were not
infected. This is occasionally observed in both human vaccinations
with Vaccinia virus where vaccinated individuals do not get a ‘‘take’’
[20], and in previous animal studies where Monkeypox virus
challenged animals do not become infected and do not produce
an immune response [12,13,15]. Further studies to evaluate both
the humoral and cellular immune responses are needed in order to
understand their roles in the resolution of OPXV infection.
This study is the first report describing the pathogenesis of a NA
OPXV infection in a potential rodent reservoir. Previous field
studies have shown that VPXV is endemic to California’s San
Francisco Bay area and although lesions were observed on wild
caught animals, little was known regarding the pathogenesis of this
virus in mice. The California mouse is both geographically and
ecologically sympatric with Pinyon mice and VPXV. The data
from this study clearly indicate that P. californicus is susceptible to
VPXV infection via the intranasal route, and that the subsequent
infection can cause extreme morbidity and high mortality. It is
beyond the scope of this study to characterize the pathogenesis
resulting from other routes of inoculation, it is quite possible that
sub-cutaneous or intra-muscular exposure could result in different
disease courses. Future efforts should consider this in order to
increase our understanding of Volepox virus pathogenesis. When
comparing this model with MPXV infection in prairie dogs, we
noticed that prairie dogs shed higher amounts of viable virus orally
(up to 1 6106 PFU/mL), even when inoculated with lower doses
of MPXV (86102 PFU) [13]. Swabs of the anus, eyes, and oral
cavity had lower levels of VPXV than did the solid organ tissues,
but both tissues and swabs of the infected animals had consistently
high viral loads, which in all cases exceed the inoculation dose
used in this investigation. Lung and liver contained the most viable
virus (up to 26109 PFU/mL). This could indicate that VPXV
infections may occur in wild California mice and could be
transmitted between individuals in a population; however, it is
noteworthy that two of the inoculated individuals that did not
become infected were co-housed with two infected animals.
Table 2. Presence of western blot bands (kDa) in California mice infected with volepox virus.
Non survivors
*Day 6 ID # 11 14 18 21 25 32 36 39 62 75
6 PC 007 P
6 PC 011 P P
6 PC 012 P P
6 PC 014 P P P
6 PC 020 P P P
6 PC 030 P
7 PC 008 P
7 PC 018 P
7 ,PC 024
7 ,PC 027
7 PC 034 P P P
8 PC 022 P P P
8 PC 037 P P P
Survivors
21 PC 015 P P P P P P
35 PC 009 P P P
35 PC 013 P P P
42 ,PC 010
42 PC 016 P P P
42 PC 021 P P P P P P
49 ,PC 017
49 PC 023 P P P P P P P P
49 PC 029 P P P P
56 PC 026 P P P P
56 PC 032 P P P
*Day post infection.
uMouse identificacion number. P, present.
,Mice did not show evidence of immune response.
doi:10.1371/journal.pone.0043881.t002
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Several other species within the genus OPXV are rodent-borne
and recognized as the causative agents of a febrile rash illness in
humans. Additionally, evidence suggests that OPXV Variola virus,
the causative agent of human smallpox, was initially a rodent-
borne virus before evolving into an exclusively human pathogen
[4]. The morbidity and mortality indices observed in this study are
greater than previously reported in several models of OPXV
disease, even those seen in highly pathogenic species (e.g.,
monkeypox virus and variola virus). The mouse and vole species
in which VPXV is found, are non-commensal species that have
relatively little contact with humans (as compared to species such
as Peromyscus maniculatus); thus, it is possible that this virus has had
little chance for transmission between the rodent hosts and
humans. Due to our limited knowledge of the natural history of
VPXV additional surveillance and laboratory animal studies
should be pursued to address its potential risks for other animal
(small mammal) and human populations.
Materials and Methods
Animals
Thirty one adult (17 months old) California mice were
obtained from the Peromyscus Genetic Stock Center (University
of South Carolina). The California mouse is sympatric with
Pinyon mice, and is a congeneric relative. The mice utilized for
this study laboratory raised and pathogen free,and prescreened
for the absence of anti-VPXV and anti-Vaccinia virus
antibodies in serum by enzyme-linked immunosorbent assay
(ELISA). Additionally, blood and swabs from the oral cavity,
eyes, and anus were screened by real time-PCR (RT-PCR) for
the detection of VPXV DNA. Animals were pair housed in
cages with aerosol filter tops. Standard mouse husbandry
practices were performed during the experiment in accordance
with CDC Institutional Animal Care and Use Committee
(IACUC) guidelines under the approved protocol 2126-CAR-
MOUC-A3. In addition to mouse chow all animals received
oats, hay, and dried fruit as appetence monitors, as well as a
plastic nest and enrichment nesting materials. Daily observations
of the animal’s food consumption, activity level, and general
appearance were recorded. Temperatures and weights were
recorded three times a week. Hard tissues and swabs samples
were taken during necropsy. All animals that lost 25% of their
body weight or a total of 10 points using the following clinical
scale were humanely euthanized: 2 points for decreased activity,
3 points for lethargy or innapetance, and 5 points for breathing
difficulties or recumbence. Euthanasia was performed under
anesthesia with 5% isoflurane gas by intracardiac exsanguina-
tion followed by cervical dislocation. On day 21, one survivor
Figure 3. Hematoxylin-eosin stain of liver tissue. The arrow head indicates an example of cell necrosis (hepatocytes with homogeneously
eosinophilic, or pink, cytoplasm and pyknotic or karyolytic nuclei). Hepatocytes occasionally have small basophilic intracytoplasmic inclusions
observed in dark blue (arrow).
doi:10.1371/journal.pone.0043881.g003
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(Peromyscus californicus (PC) 015) was euthanized to determine if
the animal had cleared infection. The rest of the California
mice (10 animals) that survived infection were included in an
oral rabies recombinant vaccine study, and were euthanized on
days 35 (n = 2), 42 (n = 3), 49 (n = 3) or 56 (n = 2) post VPXV
infection.
Virus and Inoculum Preparation
The virus strain VPXV_USA_1985_CA was used for inocula-
tion of animals in this study. It has been fully sequenced (Gene
banks accession number: FJ807737–45), twice passaged in BSC-40
(ATCCH african green monkey kidney) cells, and purified by two
sucrose cushions [21,22]. The purified viral inoculum was diluted
in phosphate-buffered saline (PBS) and titrated to verify concen-
tration. Twenty-four P. californicus were inoculated intranasally (IN)
with 1.6 6 103 PFU of VPXV in 10 ml of PBS (5 ml per nostril)
under anesthesia with 5% isoflurane gas. We choose the IN route
to mimic the possibility of natural infection via contact with
infected animal fluids or aerosols during social interactions. The
target dose was 56103 PFU in 10 ul based on previously reported
Orthopoxvirus animal models [12,13,15] but our final titeration
showed that the actual inoculum was 1.66103 PFU in 10 ul.
Additionally, seven animals were mock infected with 10 ml of PBS
under the same conditions. The inoculation day was considered
day zero. All days were recorded as days post inoculation (pi).
Specimen Collection and Preparation
Specimens taken during necropsy (brain, gonad, kidney, liver,
lung, spleen, submandibular lymph node, and adrenal gland) were
collected according to IACUC and CDC standard policies. In
some animals, additional organs were taken if gross lesions were
observed (e.g., bladder, intestine, pancreas, skin, and/or tongue).
Oral, ocular, anal, and lesion swabs were processed using the
Swab Extraction Tube System (Roche), and tissue samples were
homogenized using the GenoGrinder 2000 (SPEX Sample Prep)
as previously described [12,14]. DNA was extracted using Qiagen
tissue kits on the BioRobotH EZ1 workstation, according to the
manufacturer’s instructions.
Viral DNA Analysis
All samples were tested induplicate using the NAOPXV RT-PCR
assay, which targets the myristylated protein gene [23]. If only one of
the duplicates had a positive amplification, the sample was tested a
second time. Inaddition to the sample, every reaction plate contained
both a positive and negative control; the positive control consisted of
serial 10-fold dilutions of VPXV DNA (1 nanogram –10 femtogram)
and the negative control consisted ofdeionized, demineralized water.
A sample with CT value (the cycle when fluorescence crossed the
threshold) of #37 was considered positive.
Figure 4. Immunohistochemical test results showing abundant volepox antigen. The antigen stained in red (arrow heads) within epithelial
cells of a stomach specimen.
doi:10.1371/journal.pone.0043881.g004
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Virus-tissue Infectivity
BSC-40 cell monolayers were inoculated with 10-fold dilutions
of sonicated tissue homogenate or swab eluate. Infected cells were
incubated at 35.5uC in a 6% CO2 atmosphere in semi-solid
medium (Roswell Park Memorial Institute medium+1% carboxy-
methylcellulose, 2% fetal bovine serum, and 1% penicillin/
streptomycin). Cell infection was monitored microscopically by
observation of OPXV characteristic cytopathic effect. At 48 hrs
post inoculation, cells were stained with 2X crystal violet and
plaques were counted to determine the viral titer in plaque
forming units/mL (PFU/mL).
Serological Analysis
ELISA was used for detection of NA OPXV immunoglobulin
type G (IgG). We modified a previously described assay [14], using
crude VPXV at 0.05 mg/well for coating the microtiter plates.
Animal sera were tested at a 1:100 dilution, 100 ml/well of a
1:1000 dilution of anti-Peromyscus IgG (H+L HRP-labeled
antibodies, Kirkegaard & Perry Laboratories #14-33-06) were
used as conjugate. Positive and negative rabbit anti-vaccinia sera
were used as assay controls on every plate. The average of all
optical densities values from the BSC-40 cell lysate half of each
plate, plus two standard deviations, was used to generate a cut-off
value (COV). A sample’s value was considered negative if the
average of the duplicates was below the COV.
Western blots (WB) were performed following the standard
protocol for polyacrylamide gradient gels and polyvinylidene
difluoride membranes (Bio-Rad Laboratories, CA). Fifteen mg of
pure VPXV protein per well were loaded. After the protein was
transferred, the membrane was placed in the BenchProTM 4100
Western Processing System (Invitrogen, CA) for 16 hrs. Steps
included: blocking for 2 hrs (nonfat dry milk, Bio-Rad #170-
6404XTU), washing 3610 minutes each (PBS+0.1% Tween 20),
primary antibody incubation (1:1000 mice serum dilution in
blocking buffer) for 6 hrs, washing 3610 minutes each, secondary
antibody exposure using anti-Peromyscus IgG (H+L) AP-labeled
antibodies (Kirkegaard & Perry Laboratories #15-33-06) at
1:3000 dilution in blocking buffer for 6 hrs, and washing 3 6
for 20 minutes each. Blots were developed by adding Immun-
StarTM AP substrate (Bio-Rad #170-5018) for 5 minutes, followed
by autoradiography exposure.
Hematology
EDTA blood was collected from infected and non-infected
animals. Utilizing the VetScanH HM5 (Abaxis, Sunnyvale, CA) we
determined the values for total red blood cell counts, white blood
cell counts, white blood cell differentials, platelet counts, total
hemoglobin, hematocrit values, mean cell volume, mean corpus-
cular volume, and mean corpuscular hemoglobin concentration.
The normal range of hematology values from P.leucopus reported
previously [24] were used, as these values were similar to baseline




Tissue specimens were fixed in 10% neutral buffered formalin,
embedded in paraffin, and sectioned at 4 mm. Routine hematox-
ylin-eosin (H&E) stains were performed for histopathological
evaluation. Immunohistochemical tests using a multi-step immu-
noalkaline phosphatase technique were performed on sections
using a previously described technique for viruses [25]. The
primary antibody used for this test was a rabbit polyclonal anti-
monkeypox virus antibody known to cross react with other
OPXV, including VPXV, in formalin fixed, paraffin-embedded
tissue(unpublished data). Positive and negative controls were run
in parallel. For ultrastructural analysis, H&E stained sections were
processed for thin-section electron microscopy. Briefly, sections
were prepared on-slide and processed through a graded ethanol
series to rehydrate the tissue for osmium tetroxide fixation. Tissue
was then block stained with uranyl acetate and rinsed with water.
The sample was microwave processed with ethanol to dehydrate,
followed by acetone to prepare the tissue for resin infiltration.
Following four exchanges of resin, the tissue was polymerized in a
final exchange of resin at 60uC. Thin sections were cut and stained
with uranyl acetate and lead citrate before viewing sections on the
electron microscope (Tecnai Spirit, FEI, Hillsboro, OR).
Statistical Analysis
Wilcoxon rank-sum test (R Development Core Team. Vienna,
Austria, 2008, ISBN 3-900051-07-0, URL http://www.R-project.
org.) [26,27] was used to compare weight loss, temperature,
survivorship by sex, and viral titers between individuals. Day zero
values were used as the baseline. A p-value less than 0.05 was
considered statistically significant.
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